Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2013-06-24 19:48 2013-06-24 MELA STRATA Skin Sciences, Inc. Coradini Robert Director, Officer BUY $0.72 50,000 $35,990 71,457
2013-06-22 00:30 2013-06-19 ANIK Anika Therapeutics Inc. SHERWOOD CHARLES H Director, Officer OPT+S $18.00 1,847 $33,246 358,780
2013-06-21 17:15 2013-06-21 MELA STRATA Skin Sciences, Inc. Swintek Kathryn B Director BUY $0.79 3,000 $2,370 3,000
2013-06-20 23:06 2013-06-18 PDEX PRO DEX INC Swenson Nicholas John Director, 10% owner BUY $1.90 1,279 $2,430 681,032
2013-06-20 16:38 2013-06-18 BONE Xtant Medical Holdings, Inc. COOK GUY S 10% owner SELL $0.52 372,859 $195,005 5,264,729
2013-06-20 23:05 2013-06-18 PDEX PRO DEX INC CABILLOT RAYMOND E Director BUY $1.90 1,279 $2,430 314,650
2013-06-20 23:42 2013-06-18 HAE HAEMONETICS CORP LINDOP CHRISTOPHER J Officer OPT+S $42.50 68,628 $2,916,690 30,414
2013-06-20 22:17 2013-06-20 SYK STRYKER CORP STRYKER RONDA E Director SELL $64.85 7,000 $453,935 12,197,682
2013-06-21 02:54 2013-06-18 LMAT LEMAITRE VASCULAR INC Roberts David B Director, Officer OPT+S $6.75 400 $2,700 218,338
2013-06-20 23:06 2013-06-18 LMAT LEMAITRE VASCULAR INC LeMaitre Cornelia W Director, Officer SELL $6.75 332 $2,241 234,765
2013-06-20 22:12 2013-06-19 ATRC AtriCure, Inc. JOHNSTON RICHARD M Director SELL $8.96 29,348 $262,958 40,327
2013-06-19 23:38 2013-06-17 SYK STRYKER CORP STRYKER RONDA E Director SELL $67.85 21,000 $1,424,825 12,204,682
2013-06-20 00:01 2013-06-19 MELA STRATA Skin Sciences, Inc. STONE DAVID K Director BUY $0.82 10,000 $8,195 10,000
2013-06-19 21:51 2013-06-17 ATRC AtriCure, Inc. JOHNSTON RICHARD M Director SELL $9.18 39,682 $364,293 41,970
2013-06-18 23:38 2013-06-14 HAE HAEMONETICS CORP Kelly Michael P Officer OPT+S $42.17 1,400 $59,034 11,736
2013-06-18 00:13 2013-06-13 DXCM DEXCOM INC Balo Andrew K Officer OPT+S $21.90 10,000 $219,015 144,571
2013-06-18 01:21 2013-06-13 ATRC AtriCure, Inc. JOHNSTON RICHARD M Director SELL $8.97 95,598 $857,418 44,192
2013-06-14 20:15 2013-06-13 BONE Xtant Medical Holdings, Inc. Swanson Kent L Director BUY $0.55 100,000 $55,000 350,000
2013-06-14 20:20 2013-06-12 SYK STRYKER CORP STRYKER RONDA E Director SELL $66.99 21,000 $1,406,704 12,225,682
2013-06-13 23:05 2013-06-11 PDEX PRO DEX INC Swenson Nicholas John Director, 10% owner BUY $1.90 4,950 $9,405 674,943
2013-06-13 23:46 2013-06-13 BONE Xtant Medical Holdings, Inc. COOK GUY S 10% owner SELL $0.55 175,000 $96,250 5,637,588
2013-06-13 23:41 2013-06-12 BONE Xtant Medical Holdings, Inc. COOK GUY S 10% owner SELL $0.55 2,600 $1,430 5,812,588
2013-06-13 23:06 2013-06-11 PDEX PRO DEX INC CABILLOT RAYMOND E Director BUY $1.90 4,950 $9,405 308,561
2013-06-14 04:44 2013-06-11 ATRC AtriCure, Inc. JOHNSTON RICHARD M Director SELL $9.01 35,372 $318,702 49,546
2013-06-12 15:30 2013-06-11 BONE Xtant Medical Holdings, Inc. COOK GUY S 10% owner SELL $0.56 21,000 $11,760 5,815,188
2013-06-12 15:16 2013-06-10 BONE Xtant Medical Holdings, Inc. COOK GUY S 10% owner SELL $0.56 13,400 $7,504 5,836,188
2013-06-12 23:34 2013-06-11 MRIC ClearPoint Neuro, Inc. PIETRANGELO MICHAEL Director BUY $1.10 41,855 $46,041 339,024
2013-06-12 18:27 2013-06-10 SYK STRYKER CORP STRYKER RONDA E Director SELL $67.04 14,000 $938,529 12,246,682
2013-06-13 00:20 2013-06-11 DXCM DEXCOM INC LISTER JOHN Officer SELL $22.43 2,000 $44,860 77,763
2013-06-13 00:19 2013-06-11 DXCM DEXCOM INC ROPER JESS Officer SELL $22.33 10,361 $231,361 71,290
2013-06-13 00:19 2013-06-11 DXCM DEXCOM INC Pacelli Steven Robert Officer SELL $22.31 5,000 $111,550 208,513
2013-06-12 00:15 2013-06-10 BONE Xtant Medical Holdings, Inc. COOK GUY S 10% owner SELL $0.56 13,400 $7,504 11,836,188
2013-06-12 01:02 2013-06-07 SNWV SANUWAVE Health, Inc. Cashman Christopher M 10% owner SELL $0.80 34,800 $27,812 245,530
2013-06-12 01:34 2012-08-08 GMED GLOBUS MEDICAL INC Payne Steven Officer SELL $11.16 2,305 $25,724 20,771
2013-06-12 00:17 2013-06-07 PODD INSULET CORP Diehl R Anthony Officer OPT+S $30.50 38,455 $1,172,835 33,500
2013-06-10 22:29 2013-06-07 BONE Xtant Medical Holdings, Inc. COOK GUY S 10% owner SELL $0.56 88,000 $49,403 5,849,588
2013-06-07 23:58 2013-06-06 SYK STRYKER CORP STRYKER RONDA E Director SELL $66.55 14,000 $931,745 12,260,682
2013-06-08 00:04 2013-06-05 LMAT LEMAITRE VASCULAR INC Linden Robert V Officer SELL $6.45 9,383 $60,563 6,522
2013-06-08 00:07 2013-06-05 CRY Artivion Inc. McCall Ronald D Director SELL $6.15 4,000 $24,601 143,162
2013-06-07 02:03 2013-06-04 SNWV SANUWAVE Health, Inc. Cashman Christopher M 10% owner SELL $0.89 46,100 $40,983 280,330
2013-06-06 03:45 2013-06-03 RMD RESMED INC Douglas Robert Andrew Officer OPT+S $47.96 8,000 $383,680 97,481
2013-06-05 23:26 2013-06-03 HAE HAEMONETICS CORP CONCANNON BRIAN Director, Officer OPT+S $41.15 13,000 $534,955 115,798
2013-06-05 20:59 2013-06-04 SYK STRYKER CORP STRYKER RONDA E Director SELL $66.42 14,000 $929,872 12,274,682
2013-06-05 23:38 2013-06-05 ECI ENCISION INC PERNER FRED Officer BUY $1.10 2,500 $2,750 104,587
2013-06-06 02:01 2013-06-05 ECI ENCISION INC PERNER FRED Officer BUY $1.10 2,500 $2,750 30,000
2013-06-05 23:57 2013-06-03 PODD INSULET CORP DeSisto Duane Director, Officer OPT+S $29.76 20,000 $595,100 182,023
2013-06-06 00:05 2013-06-03 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer SELL $21.32 19,000 $405,128 786,889
2013-06-05 00:02 2013-05-31 BSX BOSTON SCIENTIFIC CORP Mirviss Jeffrey B. Officer SELL $9.37 10,941 $102,467 62,957
2013-06-04 23:11 2013-05-31 PDEX PRO DEX INC Swenson Nicholas John Director, 10% owner BUY $1.90 12,303 $23,376 667,212
2013-06-04 23:15 2013-05-31 PDEX PRO DEX INC CABILLOT RAYMOND E Director BUY $1.90 12,303 $23,376 300,830
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.